Opportunity Information: Apply for PAS 18 557
The National Institutes of Health (NIH) funding opportunity PAS 18 557, titled "Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)," supports research aimed at improving how alcohol-related interventions are selected, delivered, and scaled for people living with HIV. The grant is motivated by the well-documented reality that HIV-positive individuals who drink alcohol, especially those with unhealthy or heavy use, face higher risks of missing medications, experiencing faster disease progression, encountering drug toxicities and other complications such as organ damage, and struggling to maintain viral suppression. These outcomes increase the likelihood of HIV transmission and contribute to preventable illness and early mortality, which makes alcohol use a serious and persistent barrier to successful HIV prevention and care.
A key emphasis of this opportunity is that the science and tools available to researchers and clinicians have advanced, creating new ways to strengthen HIV and alcohol-focused implementation research. Applicants are encouraged to take advantage of developments such as newer pharmacologic agents, more informative biomarkers (including alcohol use and inflammation markers), and technology platforms like internet-based interventions, mobile health tools, and other digital approaches that can support screening, monitoring, engagement, and adherence. The broader idea is to move beyond simply showing that an intervention can work in ideal conditions, and instead generate practical evidence about what works best, for whom, and under which real-world circumstances across the spectrum of alcohol use severity and patterns.
The solicitation is organized around two main research directions, and applicants may address one or both. The first topic focuses on comparative effectiveness research, meaning studies that directly compare interventions or strategies to determine which approaches yield better outcomes in real settings. Within this topic, NIH is looking for research that clarifies factors tied to early detection of alcohol problems, successful patient engagement and retention in both alcohol and HIV care, and the ability to achieve and sustain optimal treatment responses. This includes examining how outcomes differ across diverse clinical environments and populations, and identifying patient-level and provider-level characteristics that influence which strategies are most effective.
The second topic emphasizes implementation approaches, specifically modeling and testing different ways to improve the uptake, delivery, and scale-up of interventions that already have evidence behind them. Here, the goal is to understand and overcome the real barriers that prevent effective alcohol-related services from being consistently integrated into HIV care. Proposed work can focus on organizational, financial, and structural issues that either support or block implementation, such as staffing models, clinic workflows, reimbursement and funding constraints, training and supervision needs, referral systems, and the broader service landscape linking HIV care to substance use treatment. Research under this topic is also intended to reduce HIV transmission and slow disease progression by improving how consistently patients receive effective alcohol interventions as part of routine HIV care.
The overall purpose of the program is to generate findings that can guide clinical decision-making and health system choices, so that evidence-based alcohol interventions are implemented in ways that genuinely improve prevention, care, and long-term health outcomes for people living with HIV. The R01 mechanism allows for substantial, multi-year research projects, and clinical trials are optional, meaning applicants can propose clinical trials when appropriate but are not required to do so.
In terms of basic administrative details, this is a discretionary grant program in the health category (CFDA 93.273) administered by NIH. The listed award ceiling is $500,000. The original closing date shown in the source information is 2020-05-07, and the opportunity was created on 2018-01-02. Eligibility is broad and includes many types of organizations such as public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and multiple levels of government (state, county, city/township, special districts), along with tribal governments and tribal organizations. The announcement also highlights additional eligible applicants including Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities, faith-based and community-based organizations, U.S. territories or possessions, and even non-U.S. entities and regional organizations, signaling an interest in diverse settings and communities where HIV and alcohol use intersect.Apply for PAS 18 557
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2018-01-02.
- Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH PAS 18 557 - Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
1) What is PAS 18 557?
PAS 18 557 is a National Institutes of Health (NIH) funding opportunity titled "Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)." It supports research designed to improve how alcohol-related interventions are selected, delivered, and scaled for people living with HIV.
2) What problem is this grant trying to address?
The opportunity is motivated by evidence that alcohol use among people living with HIV (especially unhealthy or heavy use) is associated with missed medications, faster disease progression, drug toxicities, complications such as organ damage, and difficulty maintaining viral suppression. These outcomes can increase the likelihood of HIV transmission and contribute to preventable illness and early mortality, making alcohol use a persistent barrier to successful HIV prevention and care.
3) What is the overall purpose of the program?
The purpose is to generate findings that guide clinical decision-making and health system choices so evidence-based alcohol interventions are implemented in ways that improve HIV prevention, care, and long-term health outcomes for people living with HIV.
4) What type of grant mechanism is used?
This opportunity uses the NIH R01 mechanism, which supports substantial, multi-year research projects.
5) Are clinical trials required?
No. Clinical trials are optional. Applicants may propose clinical trials when appropriate, but they are not required to do so.
6) What are the main research directions supported under this opportunity?
The solicitation is organized around two main research directions: (1) comparative effectiveness research and (2) implementation approaches. Applicants may address one or both directions.
7) What does "comparative effectiveness research" mean in this announcement?
In this context, comparative effectiveness research refers to studies that directly compare interventions or strategies to determine which approaches produce better outcomes in real-world settings.
8) What kinds of questions can comparative effectiveness projects focus on?
Comparative effectiveness projects can focus on factors linked to early detection of alcohol problems, successful engagement and retention in alcohol and HIV care, and the ability to achieve and sustain optimal treatment responses. They can also examine how outcomes differ across diverse clinical environments and populations, and identify patient-level and provider-level characteristics associated with better outcomes for specific strategies.
9) What does the "implementation approaches" topic focus on?
The implementation topic focuses on modeling and testing ways to improve the uptake, delivery, and scale-up of interventions that already have evidence behind them, particularly within routine HIV care.
10) What kinds of real-world barriers does the implementation topic aim to address?
The announcement highlights organizational, financial, and structural barriers and facilitators that affect implementation, including staffing models, clinic workflows, reimbursement and funding constraints, training and supervision needs, referral systems, and the broader service landscape linking HIV care to substance use treatment.
11) How does the opportunity encourage applicants to use newer scientific tools and approaches?
Applicants are encouraged to take advantage of advances such as newer pharmacologic agents, more informative biomarkers (including alcohol use and inflammation markers), and technology platforms like internet-based interventions, mobile health tools, and other digital approaches that can support screening, monitoring, engagement, and adherence.
12) Why does the announcement emphasize "real-world" evidence?
The intent is to move beyond demonstrating that an intervention can work under ideal conditions and instead produce practical evidence about what works best, for whom, and under which real-world circumstances, across the spectrum of alcohol use severity and patterns.
13) What populations are the focus of this opportunity?
The research focus is on people living with HIV, particularly in the context of alcohol use and alcohol-related interventions integrated with HIV prevention and care.
14) How is this opportunity categorized administratively?
It is a discretionary grant program in the health category, with CFDA number 93.273, administered by the National Institutes of Health (NIH).
15) What is the award ceiling listed for this opportunity?
The listed award ceiling is $500,000.
16) When was this opportunity created and what closing date is listed?
The opportunity was created on 2018-01-02. The original closing date shown in the provided information is 2020-05-07.
17) Who is eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; state, county, city/township, and special district governments; tribal governments; and tribal organizations.
18) Are specific institution types and community-based organizations called out as eligible?
Yes. The announcement highlights additional eligible applicants including Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities, faith-based and community-based organizations, U.S. territories or possessions, and non-U.S. entities and regional organizations.
19) Does the opportunity allow applicants outside the United States?
Yes. The eligibility description signals that non-U.S. entities and regional organizations are included among eligible applicants.
20) What kinds of outcomes is this program ultimately trying to improve?
The program aims to improve prevention, care, and long-term health outcomes for people living with HIV by strengthening alcohol-related intervention selection, delivery, and scale-up. It also aims to reduce HIV transmission and slow disease progression by improving how consistently patients receive effective alcohol interventions as part of routine HIV care.
Browse more opportunities from the same category: Health
Next opportunity: BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed)
Previous opportunity: From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 18 557
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 18 557) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) and Clinical Trial Optional Apply for PAR 18 555 Funding Number: PAR 18 555 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tanzania Malaria Surveillance and Monitoring (TMSM) Apply for SOL72062118RFA00001 Funding Number: SOL72062118RFA00001 Agency: Tanzania USAID-Dar es Salaam Category: Health Funding Amount: $14,100,000 |
| Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional) Apply for PA 18 438 Funding Number: PA 18 438 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) Apply for PAR 18 435 Funding Number: PAR 18 435 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 - No Independent Clinical Trials) Apply for PAR 18 436 Funding Number: PAR 18 436 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Competing Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44 Clinical Trial Optional) Apply for PA 18 567 Funding Number: PA 18 567 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 - Clinical Trial Optional) Apply for PAR 18 561 Funding Number: PAR 18 561 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional) Apply for PA 18 382 Funding Number: PA 18 382 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trials Optional) Apply for PAR 18 563 Funding Number: PAR 18 563 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 -Clinical Trials Required) Apply for PAR 18 562 Funding Number: PAR 18 562 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 - No Independent Clinical Trials) Apply for PAR 18 564 Funding Number: PAR 18 564 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional Apply for PAR 18 565 Funding Number: PAR 18 565 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) Apply for PA 18 572 Funding Number: PA 18 572 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) Apply for PA 18 571 Funding Number: PA 18 571 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional) Apply for PA 18 566 Funding Number: PA 18 566 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional) Apply for PAR 18 580 Funding Number: PAR 18 580 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional) Apply for PAR 18 581 Funding Number: PAR 18 581 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed) Apply for PAR 18 582 Funding Number: PAR 18 582 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional) Apply for PAR 18 578 Funding Number: PAR 18 578 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed) Apply for PAR 18 577 Funding Number: PAR 18 577 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 18 557", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
